We recently published a list of 20 Stocks Insiders Bought in April After Trump’s Tariff Rollout. In this article, we are ...

Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb are included in this Analyst Blog.

Edgewise Therapeutics, Inc.’s EWTX share price has dipped by 28.51%, which has investors questioning if this is right time to ...

Piper Sandler reaffirmed their overweight rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research ...

Market volatility has not dissuaded some insiders from making big share purchases. The most notable transactions came from ...

Discover growth opportunities with Edgewise Therapeutics, Inc. in the hypertrophic cardiomyopathy market. Click for my EWTX ...

Shares of Edgewise Therapeutics EWTX plunged 47.7% in a week, likely due to safety concerns for its investigational candidate ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...

As previously reported yesterday, Scotiabank downgraded Edgewise Therapeutics (EWTX) to Sector Perform from Outperform with a price target of ...

Edgewise intends to use the net proceeds from the offering to support the potential U.S. commercial launch of sevasemten in patients with ...

Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) had its price target lowered by research analysts at Royal Bank of ...